Aralez Pharmaceuticals Inc.·4

Jun 15, 9:45 PM ET

Aralez Pharmaceuticals Inc. 4

4 · Aralez Pharmaceuticals Inc. · Filed Jun 15, 2016

Insider Transaction Report

Form 4
Period: 2016-06-13
Transactions
  • Exercise/Conversion

    Common Shares, without par value

    [F1]
    2016-06-13$2.82/sh+4,365$12,309277,178 total
  • Exercise/Conversion

    Stock Options (right to buy)

    [F1][F2]
    2016-06-134,3650 total
    Exercise: $2.82Exp: 2016-06-22Common Shares, without par value (4,365 underlying)
Footnotes (2)
  • [F1]Price is presented in Canadian dollars.
  • [F2]The option was exercisable as of the Reporting Person's previous filing on Form 3, dated as of February 8, 2016.
Signature
/s/ Eric L. Trachtenberg, attorney-in-fact for Francis Martin Thrasher|2016-06-15

Documents

1 file
  • 4
    a4.xmlPrimary

    4